Adipex-P 37.5mg (Phentermine)

Description

What Is Adipex-P 37.5 mg?

Adipex-P 37.5 mg is a prescription drug. It comes as an oral capsule, an oral tablet, and an orally disintegrating tablet.

Phentermine oral capsule is available as the brand-name drug Adipex-P. It’s also available as a generic drug. Generic drugs usually cost less than the brand-name version. In some cases, they may not be available in every strength or form as the brand-name drug.

Highlights For Adipex-P 37.5 mg

1. Adipex-P oral capsule is available as a brand-name drug and as a generic drug. Brand name: Adipex-P.
2. Adipex-P comes in three forms: an oral capsule, an oral tablet, and an orally disintegrating tablet.
3. Adipex-P oral capsule is used to treat obesity.

• • HIGHLIGHTS OF PRESCRIBING INFORMATION
    These highlights do not include all the information needed to use Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg safely and effectively. See full prescribing information for Phentermine …
  • Table of Contents
  • 1  INDICATIONS AND USAGE
    Phentermine hydrochloride, USP 37.5 mg is indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification, and caloric restriction in the …
  • 2  DOSAGE AND ADMINISTRATION
    2.1 Exogenous Obesity – Dosage should be individualized to obtain an adequate response with the lowest effective dose. The usual adult dose is one tablet (37.5 mg) or one capsule (37.5 mg …
  • 3  DOSAGE FORMS AND STRENGTHS
    Capsules containing 37.5 mg phentermine hydrochloride (equivalent to 30 mg phentermine base). Tablets containing 37.5 mg phentermine hydrochloride (equivalent to 30 mg phentermine base) …
  • 4  CONTRAINDICATIONS
    History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension). During or within 14 days following the administration …
  • 5  WARNINGS AND PRECAUTIONS
    5.1 Coadministration with Other Drug Products for Weight Loss – Phentermine is indicated only as short-term (a few weeks) monotherapy for the management of exogenous obesity. The safety and …
  • 6 ADVERSE REACTIONS
    The following adverse reactions are described, or described in greater detail, in other sections: Primary pulmonary hypertension [ see Warnings and Precautions ( 5.2) ] Valvular …
  • 7  DRUG INTERACTIONS
    7.1 Monoamine Oxidase Inhibitors – Use of phentermine is contraindicated during or within 14 days following the administration of monoamine oxidase inhibitors because of the risk of …
  • 8  USE IN SPECIFIC POPULATIONS
    8.1 Pregnancy – Pregnancy category X – Phentermine is contraindicated during pregnancy because weight loss offers no potential benefit to a pregnant woman and may result in fetal harm. A …
  • 9  DRUG ABUSE AND DEPENDENCE
    9.1 Controlled Substance – Phentermine is a Schedule IV controlled substance. 9.2 Abuse – Phentermine is related chemically and pharmacologically to the amphetamines. Amphetamines and …
  • 10  OVERDOSAGE
    The least amount feasible should be prescribed or dispensed at one time in order to minimize the possibility of overdosage. 10.1 Acute Overdosage – Manifestations of acute overdosage include …
  • 11 DESCRIPTION
    Phentermine hydrochloride is a sympathomimetic amine anorectic. Its chemical name is α, α-dimethylphenethylamine hydrochloride. The structural formula is as follows: Phentermine hydrochloride is …
  • 12 CLINICAL PHARMACOLOGY
    12.1 Mechanism of Action – Phentermine is a sympathomimetic amine with pharmacologic activity similar to the prototype drugs of this class used in obesity, amphetamine (d- and …
  • 13  NONCLINICAL TOXICOLOGY
    13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility – Studies have not been performed with phentermine to determine the potential for carcinogenesis, mutagenesis, or impairment of …
  • 14  CLINICAL STUDIES
    In relatively short-term clinical trials, adult obese subjects instructed in dietary management and treated with “anorectic” drugs lost more weight on the average than those treated with placebo …
  • 16 HOW SUPPLIED/STORAGE AND HANDLING
    Available in tablets and capsules containing 37.5 mg phentermine hydrochloride (equivalent to 30 mg Phentermine base). Phentermine hydrochloride capsules, USP 37.5 mg are supplied as bright blue …
  • 17 PATIENT COUNSELING INFORMATION
    Patients must be informed that phentermine hydrochloride is a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification, and caloric …
  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL – Phentermine Hydrochloride Capsules, USP 37.5 mg
    Pack Size: 30s – NDC 10702- 029-03 – PHENTERMINE HYDROCHLORIDE CAPSULES, USP – 37.5 mg – 30 CAPSULES – Rx Only – KVK-TECH, INC. Pack Size: 100s – NDC 10702- 029-01 – PHENTERMINE …
  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL – Phentermine Hydrochloride Tablets, USP 37.5 mg
    Pack Size: 30s – NDC 10702- 025-03 – PHENTERMINE HYDROCHLORIDE TABLETS, USP – 37.5 mg – 30 TABLETS – Rx Only – KVK-TECH, INC. Pack Size: 100s – NDC 10702 …